BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 6088626)

  • 1. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
    Taniguchi K; Gondo H; Nomoto K
    J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsuzaki G; Nomoto K
    J Immunol; 1990 Jul; 145(2):505-9. PubMed ID: 2114441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.
    Sado T; Kamisaku H; Kubo E
    J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of self-reactive T cells in the donor-derived T cells but not in the host-derived T cells in fully allogeneic radiation chimeras. Mls-reactive T cells in allogeneic radiation chimeras.
    Ogimoto M; Yoshikai Y; Matsuzaki G; Ohga S; Matsumoto K; Nomoto K
    Thymus; 1991 Feb; 17(1):11-22. PubMed ID: 1901675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD.
    Sykes M; Sheard M; Sachs DH
    J Immunol; 1988 Oct; 141(7):2282-8. PubMed ID: 3049804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immunological tolerance by chimeric thymus transplantation.
    Palathumpat V; VandePutte M; Waer M
    Thymus; 1989; 13(1-2):113-22. PubMed ID: 2533753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective elimination of non-lpr lymphoid cells in mice undergoing lpr-mediated graft-vs-host disease.
    Perkins DL; Michaelson J; Glaser RM; Marshak-Rothstein A
    J Immunol; 1987 Sep; 139(5):1406-13. PubMed ID: 2887617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the progenitors for thymic T cells in various organs.
    Katsura Y; Kina T; Takaoki Y; Nishikawa S
    Eur J Immunol; 1988 Jun; 18(6):889-95. PubMed ID: 3289952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.
    Bosco N; Swee LK; Bénard A; Ceredig R; Rolink A
    Exp Hematol; 2010 Mar; 38(3):222-232.e2. PubMed ID: 20045443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of NK cell activity in thymectomized bone marrow chimaeras.
    Sihvola M; Hurme M
    Immunology; 1984 Sep; 53(1):17-22. PubMed ID: 6147307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of Mls-reactive T cells in H-2-compatible but Mls-incompatible bone marrow chimeras.
    Yoshikai Y; Ogimoto M; Matsumoto K; Sakumoto M; Matsuzaki G; Nomoto K
    Eur J Immunol; 1989 Jun; 19(6):1009-13. PubMed ID: 2502418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.